ISSN: 1859 - 2872
More than 5-year survivor after chemoradiaton treatment of nasopharyngeal carcinoma: Quality of life and impact of chronic tinnitus
Main Article Content
Keywords
Abstract
Objective: To evaluate the quality of life and the impact of chronic tinnitus on more than 5-year chemoradiation for stage II-IVB nasopharyngeal carcinoma survivor. Analyze the association between chronic tinnitus and quality of life in the above-mentioned group. Subject and method: A descriptive study of stage II-IVB nasopharyngeal carcinoma (AJCC 7th) cases receiving chemoradiation at K Hospital from 2010-2013 with more than 5-year survival. Chronic tinnitus according to CTCAE v4.03 and quality of life. Assess the impact of chronic tinnitus on quality of life using the Cohen D impact factor. Result: From 109 cases: Average score on quality of life: Global quality of life averaged 62.9 points. Regarding the average score of functions: physical functions: 83.7 points, role functions: 78.6 points; emotional function: 75.4 points; cognitive function: 78.1 points; social function: 65.4 points. 3rd grade chronic tinnitus accounted for 8.3%. Grade 3 tinnitus had a mean quality of life score that was significantly different from the mean score of quality of life in a grade 0 person on all items of the quality of life scale, as calculated by Cohen's D. Conclusion: Grade 3 chronic tinnitus greatly affected all items of the mean quality of life scale.
Article Details
References
2. Chen L, Zhang Y, Lai SZ et al (2019) 10‐year results of therapeutic ratio by intensity‐modulated radiotherapy versus two‐dimensional radiotherapy in patients with nasopharyngeal carcinoma. The oncologist 24(1): 38-45.
3. Huang TL, Chien CY, Tsai WL, et al (2016) Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy. Head Neck, 38(1) 1026-1032.
4. Isaradisaikul SK, Chowsilpa S (2020) Ototoxicity after chemoradiotherapy for nasopharyngeal carcinoma. Ann Nasopharynx Cancer 4 9.
5. Mazurek B, Hesse G, Dobel C et al (2022) Chronic tinnitus: Diagnosis and treatment. Deutsches Ärzteblatt International 119(13): 219.
6. McDowell L, Corry J, Ringash J et al (2020) Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors. Front Oncol 10: 930.
7. Niu X, Xue F, Liu P et al (2022) Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era. Int J Med Sci 19(2): 267.
8. Salehiniya H, Mohammadian M, Mohammadian-Hafshejani A et al (2018) Nasopharyngeal cancer in the world: epidemiology, incidence, mortality and risk factors. World cancer research journal 5(1).
9. Scott NW, Fayers P, Aaronson NK et al (2008) EORTC QLQ-C30 reference values manual.
10. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71 (3): 209-249.
11. Trevis KJ, McLachlan NM, Wilson SJ (2018) A systematic review and meta-analysis of psychological functioning in chronic tinnitus. Clin Psychol Rev 60: 62-86.
Article Sidebar
